Insights

Gathering insights about Athenex…

Similar companies to Athenex

Athenex Tech Stack

Athenex uses 8 technology products and services including SAS, Fastly, Hyperion, and more. Explore Athenex's tech stack below.

SAS
Business Intelligence
Fastly
Content Delivery Network
Hyperion
Corporate Performance Management
Oracle
Enterprise
Typekit
Font Scripts
Dayforce HCM
Human Resource Management System
jQuery
Javascript Libraries
Animate.css
UI Frameworks

Media & News

Athenex sold assets to Sagent Pharmaceuticals on Jun 1st '23.
Schaumburg, Illinois-based Sagent Pharmaceuticals purchased assets from Athenex Pharmaceutical Division in a deal that closed June 30, according to the SEC filing.
Jul 31, 2023 | www.bizjournals.com
Athenex closed offices in New York, New York, United States on Aug 10th '23.
Athenex (Nasdaq: ATNX) will close both its locations — in the Conventus Building on Main Street in Buffalo and at 11342 Main St. facility in Clarence — by Aug. 10.
May 19, 2023 | www.wgrz.com
Hangauer retired from Athenex as chief scientific officer on Dec 1st '16.
While Hangauer retired from Athenex in December 2016 as chief scientific officer, he remembers the buzz around the company back then.
May 15, 2023 | buffalonews.com
Athenex partners with Quantumleaphealth.
Athenex, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions collaborated with GSK and Quantum Leap in two study arms of the I-SPY 2 TRIAL.
May 01, 2023 | www.investorsobserver.com
Athenex decreased headcount by 92 on Jan 1st '21.
In a press release, penny stock Athenex said it will exit the compounding industry and lay off 92 in the process to focus on “creating value” by focusing on advancing its cell therapy pipeline and monetizing “non-core assets.”
Jan 03, 2023 | endpts.com
Athenex closed offices in Newstead, New York, United States on Mar 17th '22.
Biopharmaceutical company Athenex is closing its Newstead manufacturing plant on Main Street and laying off all 92 employees as of March 17, according to a notice posted to the New York State Department of Labor's website under the state's WARN Act.
Dec 28, 2022 | buffalonews.com
Srivastava leaves Athenex as Vice President, Cell Therapy Development.
Dr. Srivastava joined Alaunos from Athenex, where he was Vice President, Cell Therapy Development.
Aug 15, 2022 | www.globenewswire.com

Athenex's Email Address Formats

Athenex uses at least 2 format(s):

Athenex Email Formats	Example	Percentage
FLast@athenex.com	JDoe@athenex.com	77%
FirstLast@athenex.com	JohnDoe@athenex.com	20%
FirLast@athenex.com	JohDoe@athenex.com	2%
Last.First@athenex.com	Doe.John@athenex.com	1%
FLast@kinexpharma.com	JDoe@kinexpharma.com	66%
Last@kinexpharma.com	Doe@kinexpharma.com	31%
Last_First@kinexpharma.com	Doe_John@kinexpharma.com	3%

Frequently Asked Questions

Where is Athenex's headquarters located?

Athenex's main headquarters is located at 1001 Main Street Suite 600 Buffalo, New York 14203 US. The company has employees across 4 continents, including North AmericaSouth AmericaAsia.

What is Athenex's phone number?

You can contact Athenex's main corporate office by phone at

+1-716-898-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Athenex's stock symbol?

Athenex is a publicly traded company; the company's stock symbol is ATNXQ.

What is Athenex's official website and social media links?

Athenex's official website is athenex.com and has social profiles on LinkedIn.

How much revenue does Athenex generate?

As of October 2024, Athenex's annual revenue reached $75M.

What is Athenex's SIC code NAICS code?

Athenex's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Athenex have currently?

As of October 2024, Athenex has approximately 201 employees across 4 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Executive Officer: J. L.Chief Business And Commercial Officer, Athenex: T. C.Chief Scientific Officer: D. H.. Explore Athenex's employee directory with LeadIQ.

What industry does Athenex belong to?

Athenex operates in the Pharmaceutical Manufacturing industry.

What technology does Athenex use?

Athenex's tech stack includes SASFastlyHyperionOracleTypekitDayforce HCMjQueryAnimate.css.

What is Athenex's email format?

Athenex's email format typically follows the pattern of . Find more Athenex email formats with LeadIQ.

How much funding has Athenex raised to date?

As of October 2024, Athenex has raised $30M in funding. The last funding round occurred on Aug 11, 2022 for $30M.

Athenex

Pharmaceutical ManufacturingNew York, United States201-500 Employees

Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies.

The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients.  Our business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.

Company Overview

Headquarters: 1001 Main Street Suite 600 Buffalo, New York 14203 US
Phone number: ✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-716-898-****
Website: athenex.com
SIC Code: 2834 - Pharmaceutical Preparations
Stock Symbol: ATNXQ
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Employees: 201-500

Media & News

Funding & Financials

$30M
Athenex has raised a total of $30M of funding over 10 rounds. Their latest funding round was raised on Aug 11, 2022 in the amount of $30M.
$50M$100M
Athenex's revenue is in the range of $50M$100M

Funding & Financials

$30M
Athenex has raised a total of $30M of funding over 10 rounds. Their latest funding round was raised on Aug 11, 2022 in the amount of $30M.
$50M$100M
Athenex's revenue is in the range of $50M$100M

Company Leadership

J. L.
Chief Executive Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. C.
Chief Business And Commercial Officer, Athenex
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. H.
Chief Scientific Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. R.
Chief Financial Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. K.
Chief Medical Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

E. C.
Regional Cfo
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Chairman And Ceo
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Chief Executive Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. F.
Executive Assistant & Project Specialist, Offices Of The President And Chief Operating Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. R.
Chief Financial Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Athenex

Agios Pharmaceuticals

Blueprint Medicines

Atara Biotherapeutics

Aileron Therapeutics

Mersana Therapeutics

Ikena Oncology

Athenex Tech Stack

Media & News

Athenex sold assets to Sagent Pharmaceuticals on Jun 1st '23.

Athenex closed offices in New York, New York, United States on Aug 10th '23.

Hangauer retired from Athenex as chief scientific officer on Dec 1st '16.

Athenex partners with Quantumleaphealth.

Athenex decreased headcount by 92 on Jan 1st '21.

Athenex closed offices in Newstead, New York, United States on Mar 17th '22.

Srivastava leaves Athenex as Vice President, Cell Therapy Development.

Athenex's Email Address Formats

Frequently Asked Questions

Where is Athenex's headquarters located?

What is Athenex's phone number?

What is Athenex's stock symbol?

What is Athenex's official website and social media links?

How much revenue does Athenex generate?

What is Athenex's SIC code NAICS code?

How many employees does Athenex have currently?

What industry does Athenex belong to?

What technology does Athenex use?

What is Athenex's email format?

How much funding has Athenex raised to date?

Athenex

Company Overview

Media & News

Athenex sold assets to Sagent Pharmaceuticals on Jun 1st '23.

Athenex closed offices in New York, New York, United States on Aug 10th '23.

Hangauer retired from Athenex as chief scientific officer on Dec 1st '16.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?